Attached files
Exhibit 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code)
Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of section 1350, chapter 63 of title 18, United States
Code), each of the undersigned officers of MabVax Therapeutics
Holdings, Inc., does hereby certify, to such officer’s
knowledge, that:
The
Quarterly Report on Form 10-Q of MabVax Therapeutics Holdings, Inc.
for the three and six months ended June 30, 2017, fully complies
with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and the information contained in the Form
10-Q fairly presents, in all material respects, the financial
condition and results of operations of MabVax Therapeutics
Holdings, Inc.
|
|
|
|
|
|
Date:
August 14, 2017
|
|
By:
|
/s/ J.
David Hansen
|
|
|
|
|
J.
David Hansen
|
|
|
|
|
Chief
Executive Officer (Principal
Executive
Officer)
|
|
|
|
|
|
|
Date:
August 14, 2017
|
|
By:
|
/s/
Gregory P. Hanson
|
|
|
|
|
Gregory
P. Hanson
|
|
|
|
|
Chief
Financial Officer (Principal
Financial
and Accounting Officer)
|
A
signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or
its staff upon request.